Abstract
The increase in plasma concentration of atrial natriuretic factor in heart transplant patients has not been fully elucidated. Besides an eventual pressure or volume overload leading to passive atrial distension, the atrial tension developed during atrial systole, or atrial ejection force, which may be increased by the transplantation procedure, is an important determinant of atrial natriuretic factor release. We therefore determined the plasma concentration of atrial natriuretic factor and the maximal atrial ejection force in 15 heart transplant patients and 8 controls, matched for age and body mass. Atrial ejection force, as defined as the force exerted by the left atrium to accelerate blood into the left ventricle during atrial systole, was obtained using combined two-dimensional imaging and doppler echocardiography. Serum creatinin concentrations, heart rate [91.9 (SD 13.2) vs 71.8 (SD 10.9) beats · min−1], mean arterial blood pressure [103.9 (SD 9.8) vs 87.4 (SD 5.8) mmHg, 13.85 (SD 1.31) vs 11.65 (SD 0.77) kPa], left ventricular posterior wall thickness and interventricular septum thickness were higher in heart transplant patients compared to controls. Plasma concentration of atrial natriuretic factor was also elevated in heart transplant patients [63.9 (SD 18.1) vs 34.0 (SD 3.2) pg · ml−1; P<0.001]. In contrast, although the left atrial area was greater in heart transplant patients [28.2 (SD 4.8) vs 15.8 (SD 2.5) cm2; P<0.001], mitral area, transmitral Doppler A-wave maximal velocity and atrial ejection force were similar in transplant and in control patients [7.7 (SD 3.5) vs 8.9 (SD 2.8) kdyn, 77 (SD 35) vs 89 (SD 28) mN]. No significant correlation was observed between concentration of atrial natriuretic factor and atrial ejection force, either in heart transplant patients or in controls. Thus, the elevated plasma concentration of atrial natriuretic factor observed in these heart transplant patients was multifactorial in origin, and was considered to depend upon an hypersecretion rather than upon a decreased clearance rate. Moreover, it is suggested that the atrial ejection force was unlikely to have participated in this enhanced release of atrial natriuretic factor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angermann CE, Spes CH, Dominiak P, Weil J, Gerzer R, Stempfle HU, Kemkes BM, Theisen K (1992) Effects of graded exercise on blood pressure, heart rate and plasma hormones in cardiac transplant recipients before and during antihypertensive therapy. Clin Invest 70:14–21
Choong CY, Herrmann HC, Weyman AE, Fifer MA (1987) Preload dependence of doppler-derived indexes of left ventricular diastolic function in humans. J Am Coll Cardiol 10:800–808
Choong CY, Abascal VM, Thomas JD, Guerrero JL, McGlew S, Weyman AE (1988) Combined influence of ventricular loading and relaxation on the transmittal velocity profile in dogs measured by doppler echocardiography. Circulation 78:672–683
Christensen G, Leistad E, Ilebekk A (1991) Active tension development, not passive atrial stretch stimulates release of atrial natriuretic factor during pacing tachycardia. Circulation 84 [Suppl 2]:628
Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJF, Scarborough RM, Lewicki JA (1986) Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 78:1362–1374
Follenius M, Brandenberger G (1988) Increase atrial natriuretic peptide in response to physiological exercise. Eur J Appl Physiol 57:159–162
Ganau A, Devereux RB, Atlas SA, Pecker M, Roman MJ, Vargia P, Cody RJ, Laragh JH (1989) Plasma atrial natriuretic factor in essential hypertension: relation to cardiac size, function and systemic hemodynamics. J Am Coll Cardiol 14:715–724
Geny B, Piquard F, Follenius M, Mettauer B, Schaefer A, Canguilhem B, Eisenmann B, Haberey P (1993) Role of cardiac innervation in atrial natriuretic peptide secretion in transplanted heart recipients. Am J Physiol 265:FI12-F118
Hollister AS, Rodeheffer RJ, White FJ, Potts JR, Imada T, Inagami T (1989) Clearance of atrial natriuretic factor by lung, liver and kidney in human subjects and the dog. J Clin Invest 83:623–628
Lambertz H, Sigmung M, Hoffmann R, Flachskampf FA, Messmer BJ, Hanrath P (1991) Transesophageal Doppler analysis of pulmonary venous flow in cardiac transplant recipients. Am Heart J 121:623–626
Manning WJ, Riley MF, Come PC (1991) Effect of balloon aortic valvuloplasty on doppler indexes of left ventricular diastolic filling. Am J cardiol 67:544–546
Manning WJ, Silverman DI, Katz SE, Douglas PS (1993) Atrial ejection force: a non invasive assessment of atrial systolic function. J Am Coll Cardiol 22:221–225
Mettauer B, Lampert E, Lonsdorfer J, Levy F, Geny B, Kretz JG, Carpentier A, Haberey P, Eisenmann B, Kieny R (1991) Cardiorespiratory and neuro-hormonal response to incremental maximal exercise of patients with denervated transplanted hearts. Transplant Proc 23:1178–1181
Myers BD, Peterson C, Molina C, Tomlanovich SJ, Newton LD, Nitkin R, Sandler H, Murad F (1988) Role of cardiac atria in the human response to changing plasma volume. Am J Physiol 254:F562-F573
Needleman P, Greenwald JE (1986) Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood pressure homeostasis. New Engl J Med 314:828–834
Oneglia C, Sabatini T, Rusconi C, Moretti R (1993) Effect of aging on pulmonary venous flow velocity pattern: an echocardiographic doppler study. Am J Noninvasive Cardiol 7:51–56
Rascher W, Tulassay T, Lang RE (1985) Atrial natriuretic peptide in plasma of volume-overload children with chronic renal failure. Lancet 11:303–305
Rubin DA, Uretsky BF, Zerbe TR, Estrada-Guintero T, Murali S (1994) Increased plasma natriuretic peptide levels after heart transplant: relation to ventricular expression and severity of rejection. Am Heart J 128:769–773
Saini J, Geny B, Brandenberger G, Mettauer B, Wittersheim G, Lampert E, Lonsdorfer J (1995) Training effects on the hydromineral endocrine responses of cardiac transplant patients. Eur J Appl Physiol 70:226–233
Singer DR, Buckley MG, MacGregor GA, Khaghani A, Banner NR, Yacoub MH (1986) Raised concentrations of plasma natriuretic peptides in cardiac transplant recipients. BMJ 293:1391–1392
Suzuki M, Almeida FA, Nussenzweig DR, Sawyer D, Maack T (1987) Binding and functional effects of atrial natriuretic factor in isolated rat kidney. Am J Physiol 253:F917–928
Takemura G, Fujiwara H, Mukoyama M, Saito Y, Nakao K, Kawamura A, Ishida M, Kida M, Uegaito T, Tanaka M (1991) Expression and distribution of atria] natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 83:181–190
Tomlanovich S, Golbetz H, Perlroth M, Stinson E, Myers BD (1986) Limitation of creatinin in quantifying the severity of Cyclosporine-induced chronic nephropathy. Am J Kidney Dis 8:332–337
Triposkiadis F, Starling RC, Hass GJ, Sparks E, Myerowitz D, Boudoulas H (1993) Timing of recipient atrial contraction: a major determinant of transmitral diastolic flow in orthotopic cardiac transplantation. Am Heart J 126:1175–1181
Walsch KP, Williams TDM, Spiteri C, Fitts E, Lightman SL, Sutton R (1988) Role of atrial pressure and rate in release of atrial natriuretic peptide. Am J Physiol 254:R607-R610
Williams JF, Sonnenblick EH, Braunwald E (1965) Determinants of atrial contractile force in the intact heart. Am J Physiol 209:1061–1068
Young JB, Wintersz WL, Bourge R, Uretsky B (1993) Function of the heart transplant recipient. J Am Coll Cardiol 22:31–41
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Geny, B., Piquard, F., Follenius, M. et al. Atrial natriuretic factor secretion: a role for atrial systolic ejection force?. Eur J Appl Physiol 72, 440–444 (1996). https://doi.org/10.1007/BF00242273
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00242273